Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Brian Culley | M | 53 | 6 years | |
Michael Mulroy | M | 58 | 10 years | |
Don Bailey | M | 78 | 8 years | |
Andy Arno | M | 64 | 10 years | |
Joshua Riggs | M | 42 | 4 years | |
Neal Bradsher | M | 58 | 15 years | |
George Samuel | M | 43 | 3 years | |
Deborah Andrews | F | 66 | 10 years | |
Andrew Last | M | 64 | 9 years | |
Louis Silverman | M | 65 | 2 years | |
Angus Russell | M | 68 | 10 years | |
Anula Kusum Jayasuriya | M | 67 | 3 years | |
James Liu | M | 29 | 3 years | |
Dipti Amin | M | 60 | 3 years | |
Jennifer Bahr-Davidson | M | - | 14 years | |
Jill Howe | F | 48 | 2 years | |
Ekkehard Schütz | M | - | 3 years | |
Derek Kelaita | M | - | 5 years | |
Frank Lanza | M | 62 | 8 years | |
Gary Hogge | M | 56 | 6 years | |
Rami Skaliter | M | 66 |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | 7 years |
Yuh-Min Chiang | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert W. Peabody | M | 69 | 8 years | |
Michael West | M | 71 | 16 years | |
Adi Mohanty | M | 57 | 6 years | |
Cavan Redmond | M | 63 | 7 years | |
Judith Segall | F | 70 | 29 years | |
Pedro Lichtinger | M | 70 | 7 years | |
Russell Skibsted | M | 65 | 4 years | |
Andrew von Eschenbach | M | 82 | 3 years | |
Ronald Andrews | M | 64 | 4 years | |
Steve Cartt | M | 61 | 5 years | |
William Annett | M | 70 | 4 years | |
Ryan D. Chavez | M | 48 | 3 years | |
Edward D. Wirth | M | 59 | 6 years | |
Henry Nordhoff | M | 82 | 1 years | |
Peter García | M | 62 | 2 years | |
Stephana Patton | M | 54 | 2 years | |
Thomas B. Okarma | M | 78 | 2 years | |
Franklin Berger | M | 74 | 1 years | |
Richard Towne LeBuhn | M | 59 | 5 years | |
Jennifer Carter | M | 60 | 3 years | |
Chase Leavitt | M | 42 | 2 years | |
Albert Parker | M | 58 | 2 years | |
Melinda Griffith | F | 69 | - | |
Padma Sundar | F | - | 3 years | |
Tony Kalajian | M | 54 | 4 years | |
Gisela Paulsen | M | 58 | 1 years | |
Kevin Cook | M | 53 | 1 years | |
Gary K. Duberstein | M | - |
Greenway Partners LP
Greenway Partners LP Investment ManagersFinance Greenway Partners LP is the hedge fund management subsidiary of Greenbelt Corp. Headquartered in New York City, the firm manages the assets of high-net-worth clients. | 8 years |
Anish John | M | 53 | 2 years | |
William Haack | M | - | 2 years | |
Abraham E. Cohen | M | 86 | - | |
David Schlachet | M | 78 | 4 years | |
Stephen Farrell | M | 59 | 7 years | |
Arnold I. Burns | M | 94 | 4 years | |
Nat Ricciardi | M | 75 | 5 years | |
Brandi Roberts | F | 50 | 2 years | |
Mitchell Levine | M | - | - | |
Jeffrey D. Janus | M | 68 |
ES Cell International Pte Ltd.
ES Cell International Pte Ltd. BiotechnologyHealth Technology ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore. | 3 years |
Howard I. Scher | M | 72 | 3 years | |
Katharine E. Spink | M | 49 | 5 years | |
François Binette | M | - | - | |
Kim Dickinson | M | - | 2 years | |
Moshe Hukaylo | M | - |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | - |
Yu Li | M | - | 1 years | |
Andrea Park | F | 52 | 14 years | |
Alexandra Hernandez | F | - | 3 years | |
Robert N. Butler | M | 97 | 2 years | |
Craig Halberstadt | M | - | - | |
David Jin | M | 56 | 8 years | |
Oscar Cuzzani | M | - | - | |
Jane S. Lebkowski | M | 68 | 4 years | |
Kristine C. Mechem | M | - | 4 years | |
Karen B. Chapman | M | - | 6 years | |
Lyndal K. Hesterberg | M | - | 4 years | |
Kirk Trisler | M | 64 | 1 years | |
Georgia Erbez | F | 57 | 1 years | |
Walter Funk | M | 64 | 3 years | |
James Knight | M | - | - | |
Douglas Ross | M | 64 | 2 years | |
John Gutfreund | M | 38 | 1 years | |
Lyssa Friedman | F | - | 4 years | |
William K. Seltzer | M | - | - | |
William P. Tew | M | 77 | 4 years | |
Michael G. Vicari | M | - | 1 years | |
Lesley A. Stolz | M | 60 | 1 years | |
John Mauldin | M | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 86 | 97.73% |
Israel | 2 | 2.27% |
Singapore | 1 | 1.14% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Alfred Kingsley
- Personal Network